Delfina Care – a healthcare technology company solving the maternal health crisis with an AI-based care system – announced the successful closing of its $17 million Series A funding round led by U.S. Venture Partners (USVP). The Series A funding round was led by U.S. Venture Partners (USVP) and it included participation from new investors ARTIS Ventures, Mayo Clinic, and Tokio Marine Future Fund. Delfina’s existing investors also participated in the round, including Story Ventures, SemperVirens, Bread and Butter Ventures, Boutique Ventures, and Chelsea Clinton’s Metrodora Ventures.
This funding validates Delfina’s rapid progress in its mission to transform pregnancy care by delivering equitable access to individualized insights and integrated systems that improve health outcomes.
Delfina’s AI-based maternal health platform addresses the challenges of a growing maternal health crisis by combining award-winning predictive analytics, tailored interventions, and closed-loop connection (through data) between the patient and their primary prenatal care provider to improve outcomes for moms and babies.
And Delfina’s evidence-based approach has demonstrated measurable success for maternal and infant health. Plus, Delfina partners have observed reductions in preterm births, NICU admissions, hypertensive disorders, and gestational diabetes—the leading causes of preterm births, maternal morbidity, and mortality. Based on these improved outcomes, Delfina guarantees 3X cost savings for health plans.
KEY QUOTES:
“This funding marks a significant milestone in Delfina’s fulfillment of our mission to solve the national maternal health crisis. We are grateful for the support of our investors and partners who share our commitment to improving outcomes for moms and babies. With this capital, Delfina will accelerate serving diverse populations, scale our impact nationally, and evolve our market-leading AI-powered predictive technology to continue delivering proven results for our partners nationwide.”
- Senan Ebrahim, MD, PhD, CEO and Founder of Delfina
“Since we transformed our practice with Delfina Care, we have seen the positive impact on our pregnant patients’ care every day. We see many patients whose cardiovascular and metabolic challenges we can now proactively manage thanks to Delfina’s insights. Our clinicians have been empowered by Delfina’s system to efficiently provide a new level of proactive care for healthy pregnancy outcomes.”
- Fatimah Lalani, DO, Chief Medical Officer of HOPE Clinic in Houston, Texas
“Delfina’s care system is built on the most advanced machine learning technology that creates the most measurable impact for our healthcare system. We are excited to see the lifesaving application of this cutting-edge tech to maternal health. We are thrilled to join Delfina in delivering the future of pregnancy care to all families.”
- Dafina Toncheva, USVP General Partner
